Reynold Homan

Title: The Innovative Contributions of Reynold Homan

Introduction

Reynold Homan is a notable inventor based in Ann Arbor, MI, who has made significant contributions to the field of drug formulation and detection methods. With a total of seven patents to his name, Homan's work focuses on enhancing the efficacy of hydrophobic drugs and developing methods for measuring specific enzyme activities.

Latest Patents

Homan's latest patents include innovative formulations aimed at improving the efficacy of hydrophobic drugs. One of his key inventions is a novel amphiphilic peptide and peptide amphiphile lipid micelles, which are designed to enhance drug delivery. Additionally, he has developed processes for creating these micelles that incorporate an amphiphilic peptide and phospholipid, along with optional cargo molecules. Another significant patent involves the detection of lecithin:cholesterol acyltransferase (LCAT) activity. This patent outlines methods for measuring LCAT activity in various solutions, including serum and plasma, using fluorescent sterol substrates. It also includes methods for evaluating the efficacy of therapeutic agents that stimulate LCAT activity.

Career Highlights

Throughout his career, Homan has worked with prominent companies, including Warner-Lambert Company. His experience in the pharmaceutical industry has allowed him to develop groundbreaking technologies that address critical health challenges.

Collaborations

Homan has collaborated with notable professionals in his field, including Bruce J. Auerbach and Brian Krause. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Reynold Homan's innovative work in drug formulation and enzyme detection has made a significant impact in the field of pharmaceuticals. His contributions continue to influence research and development in improving drug efficacy and diagnostic methods.